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In situ-loading transfection of short single- and double-stranded DNAs 
by supramolecular organic frameworks 
Bo Yang1, Xiao-Dan Zhang2, Jian Li3, Jia Tian1, Yi-Peng Wu1, Lu Zhou2, Fa-Xing Yu3, Ruibing 
Wang4, Yi Liu5, Hui Wang1, Dan-Wei Zhang1 & Zhan-Ting Li1 
Abstract 
Short DNAs represent an important class of biomacromolecules that are widely applied in gene 
therapy, editing and modulation. However, the development of simple and reliable methods for their 
intracellular delivery is still a challenge. We herein describe that seven water-soluble homogeneous 
supramolecular organic frameworks (SOFs) with well-defined pore size and high stability in water 
can realize in-situ inclusion of ss- and dsDNAs (21, 23 and 58 nt) and deliver them into two normal 
cells or six cancer cells. Fluorescence quenching experiments for single and double end-labeled ss-
DNAs (21 and 58 nt) support that the DNA sequences can be completely included by the 
frameworks. Confocal laser scanning microscopy and flow cytometry reveal that five SOFs exhibit 
excellent transfection efficiency that outperform the commercial reagent Lipo2000 even at low 
SOF-nucleic acid ratios. In addition to higher transfection efficiency, the water-soluble self-
assembled SOF carriers have the advantages of convenient preparation, high stability and in situ 
DNA inclusion, which are all crucially required for practical use.  
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Intracellular delivery of exogenous DNAs is a key factor for the development of gene therapy and 
editing1-4. Owing to their clinical applications and potentials, short DNAs have been important 
targets of delivery studies5-8. Viral vectors have been demonstrated to be highly efficient, but suffer 
from safety concern, high cost, and scale-up difficulty9-11. In the past two decades, non-viral 
cationic vectors, in particular liposomes12,13, dendrimers14-16, polymers17-21, and nanoparticles22-25, 
have been extensively investigated through multivalent electrostatic interaction with DNAs and 
achieved considerable success. However, relatively high cytotoxicity, limited transfection efficiency 
and lack of precision remain as obstacles for their clinical trials. Materials with defined porosity are 
structurally suitable for DNA inclusion because their inherent pores are expected to avoid 
unrequired entanglement of included DNAs, which may restrain reversible gene release. 
Nevertheless, reported vectors of this family have been limited to solid-state structures26-28, the slow 
metabolism of which may cause detrimental internal aggregation. The development of water-
soluble cationic porous frameworks that are able to operate in a homogeneous manner is expected 
to integrate the advantages of the above two kinds of vectors. However, this possibility has not been 
realized. 
We have recently developed a general strategy for the generation of water-soluble three-
dimensional (3D) supramolecular organic frameworks (SOFs) from the co-assembly of 
preorganized multicationic monomers with cucurbit[8]uril (CB[8])29-32. As a family of self-
assembled water-soluble porous polyelectrolytes, diamondoid SOFs were demonstrated to adsorb 
anionic guests and deliver adsorbed chemotherapeutic reagents, such as pemetrexed, into tumor 
cells.33 We herein describe that two kinds of SOFs, which have a pore size of approximately 2.2 or 
2.0 nm, can include short single- or double-stranded (ss- and ds-) DNAs (21, 23 and 58 nt), which is 
readily realized by simply mixing the two samples, and deliver the DNAs into normal and cancer 
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cells. We demonstrate that, out of 126 delivery experiments, 98 cases can achieve a delivery 
efficacy surpassing that of Lipo2000, a commercial transfection reagent.  
Results 
Monomers of SOF vectors. Diamondoid SOFs are regular porous supramolecular 
polyelectrolytes co-assembled by tetracationic monomers and CB[8]31,32. With (4-
phenyl)pyridinium as binding subunit through the CB[8] encapsulation-enhanced dimerization 
binding motif34-37, the water-soluble polycationic frameworks form ordered pores that have a size of 
approximately 2.2 nm29. Previously, we demonstrated their robustness as molecular drug carriers to 
attain intracellular transport and low cytotoxicity33,40. Given the polyanionic feature of DNA and the 
approximately 2.0 nm diameter of dsDNAs38,39, it is conceivable that diamondoid SOFs are suitable 
carriers for the inclusion of both ss- and dsDNAs through multivalent electrostatic interactions,41,42 
which is the basis for all reported polycationic DNA carriers. The homogeneity of SOFs is expected 
to allow for quick DNA inclusion and reversible release after intracellular delivery. SOF-a-g, which 
are constructed from 1a-g and CB[8] (1:2), are thus used for exploiting this potential (Figure 1). 
The first six frameworks have been reported for the inclusion of discrete organic guests and for SOF 
postmodification29,43, while SOF-g was designed to test the generality of this new delivery strategy. 
 
Fig. 1 | Compounds used in this study. The structures of compounds 1a–g and CB[8]. 
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Characterization and cytotoxicity of SOF-g. The synthesis and characterization of the new 
SOF-g was discussed here in detail as an example since SOF-a-f was prepared and characterized 
previously. Tetrahedral monomer 1g was prepared from tetrakis(4-(bromomethyl)phenyl)methane 
and isoquinoline followed by ion exchange. SOF-g was prepared by dissolving the 1:2 mixture of 
1g and CB[8] in hot water. The X-ray crystallographic structure of the 2:1 mixture of N-
benzylisoquinolinium bromide (2) with CB[8] revealed that two isoquinolinium moieties were 
entrapped in the cavity of the CB[8] (Supplementary Figure 1), which evidenced the 2:1 binding 
motif of 1g and CB[8]. 1H NMR titration experiments in D2O for 2 and 1g with CB[8] further 
supported this 2:1 binding motif in water (Supplementary Figure 2). Isothermal titration calorimetry 
afforded (apparent) binding constant of 4.8  1011 M-2 for [2]2CB[8] and 2.5  1012 M-2 for the 2:1 
complex of the appended isoquinolinium subunits of 1g and CB[8] (Supplementary Figure 3), 
suggesting high stability of this binding motif and positive cooperativity for the appended 
isoquinolinium subunits of 1g.29 2D 1H NMR diffusion-ordered spectroscopic experiments for the 
mixture of 2 (2:1) and 1g (0.5:1) with CB[8] (1.0 mM) in D2O gave rise to a diffusion coefficient 
(D) of 2.5 × 10-10 and 1.1× 10-10 m2 s-1 for the signals of both components (Supplementary Figure 
4), indicating that 1g and CB[8] formed larger supramolecular entities. Dynamic light scattering 
experiments for the 1:2 solutions of 1g and CB[8] revealed the formation of large aggregates, with 
the hydrodynamic diameter (DH) ranging from 91 nm (CB[8] = 2 mM) to 31 nm (CB[8] = 0.03 
mM) (Supplementary Figure 5). Moreover, the DH values underwent little changes after the 
solutions were left to stand for 48 hours. Solution-phase synchrotron small-angle X-ray-scattering 
(SAXS) profile of the 1:2 solution of 1g and CB[8] (2.0 mM) exhibited a very weak and broad, but 
reproducible peak, which corresponded to the d-spacing around 3.4 nm (Supplementary Figure 6a). 
This spacing matched with the calculated {110} spacing (3.4 nm) of the modelled SOF-g network 
(Supplementary Figure 7), reflecting its periodicity in water. The solid-phase synchrotron SAXS 
profile afforded a quite sharp signal at 2.0 nm, which matched well with the calculated {211} 
spacing (Supplementary Figure 6b). Moreover, the solid-phase synchrotron small-angle XRD 
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profile exhibited three broad peaks around 2.8, 1.4 and 0.83 nm (Supplementary Figure 6c), 
respectively, which matched with the calculated {111}, {222} and {334} spacings. The structural 
features of SOF-g are similar to other SOFs assembled in a similar fashion (reference). With the 
framework structure confirmed, its in vitro cytotoxicity was evaluated using Human cancer (HeLa) 
cells and the Cell Counting Kit-8 (CCK-8) assay (Supplementary Figure 8). It was found that, after 
incubating for 24 h with SOF-a at 35, 180, 370 and 740 g/mL, the viability of the HeLa cells 
maintained at 89.1-97.0%, 96.1-100%, 97.0-100%, and 98.0-100%, respectively, showing the low 
cytotoxicity of this new self-assembled framework.  
Fluorescence study for the inclusion of DNAs by SOFs.  All the tetrahedral monomers 
and the corresponding SOF-a-g exhibit strong fluorescence. To investigate the inclusion of DNAs 
in SOFs, the SOF fluorescence was then recorded with incremental addition of six ss- and dsDNAs 
(ssDNA-21, ssDNA-23, ssDNA-58, dsDNA-21, dsDNA-23, and dsDNA-58, the numeric suffix 
represents the number of nucleotides in the sequence) (Figure 2 and Supplementary Table 1 and 
Supplementary Figure 9). For all the experiments, the concentration of the SOFs was kept 
unchanged ([1a-g] = 5.0 or 2.5 M). Adding the DNA samples to the solution of the SOFs induced 
significant quenching (SOF-a,b,g) or enhancement (SOF-c-f) of the emission of the SOF 
(Supplementary Figure 10 and 11). Moreover, at both concentrations of the frameworks, this 
emission quenching or enhancement exhibited a discernible inflection, which corresponded to 
saturated DNA loading. In contrast, adding excess of monosodium phosphate induced no significant 
change of the emission of the frameworks (Supplementary Figure 12). These observations 
supported that both ss- and dsDNAs were included into the interior of the SOFs through multivalent 
electrostatic interaction.41,42 Assuming the concentration of the DNAs at the inflection point to be 
the saturation inclusion concentration, the weight% of the DNAs included by the SOFs can be 
calculated (Supplementary Tables 2 and 3). It was found that at [1] = 5.0 M, the SOF carriers 
could include 18-70w% of ssDNAs and 14-32w% of dsDNAs, whereas at [1] = 2.5 M, the values 
were 12-43w% and 19-32w%, respectively. 
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The fluorescence quenching of single- and double end-labeled DNAs (Cy5-ssDNA-21, Cy5-
ssDNA-58, Cy5-ssDNA-21-FAM, HEX-ssDNA-21-Cy5, and Cy5-ssDNA-58-FAM) 
(Supplementary Table 1) by SOFs was also investigated. In all the cases, the quenching of the 
fluorescence probes also displayed an inflection when about 6~20 molar equivalent of SOFs was 
added (Figures 2g-l and Supplementary Figures 13-20), and the longer DNA requires more 
equivalent of SOFs for reaching the saturation. When normalized by the cation/anion charge ratio, 
the above equivalence translates to a ratio of 1.0~1.4 between the total cation concentration of SOF 
and the total anion concentration of the DNA. These results strongly support that these DNA strands 
are effectively included within the frameworks to reach a charge balance. 
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Fig. 2 | Fluorescence titration experiments. Fluorescence quenching plots of SOF-a 
([1a] = 5.0 M) in water with the addition of (a) ssDNA-21, (b) ssDNA-23, (c) ssDNA-58, 
(d) dsDNA-21, (e) dsDNA-23, and (f) dsDNA-58. SOF-a-induced fluorescence quenching 
plots of (g) Cy5-ssDNA-21 ( = 670 nm), (h) Cy5-ssDNA-58 ( = 670 nm), (i) Cy5-ssDNA-
21-FAM (Cy5,  = 670 nm), (j) Cy5-ssDNA-58-FAM (Cy5,  = 670 nm), (k) Cy5-ssDNA-21-
FAM (FAM,  = 518 nm), and (l) Cy5-ssDNA-58-FAM (FAM,  = 518 nm), highlighting a 
clear inflection point in every titration. 
Isothermal titration calorimetric (ITC) experiments. To quantitatively evaluate the inclusion 
of SOFs for DNAs,44 ITC experiments were performed for SOF-a and SOF-g and the above six ss- 
and dsDNAs (Figure 3 and Supplementary Figures 21a-d). As the inclusion occurred 
homogeneously, it was expected that, once being included into the interior of the frameworks, linear 
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nucleic acids might adopt extended or crooked conformations. Control ITC experiments revealed 
that neither monosodium phosphate nor simple nucleotides interacted with SOFs. Thus, the strong 
interactions between SOFs and nucleic acids can be attributed to mainly the multivalent 
electrostatic interactions between the pyridinium or isoquinolinium cations and the phosphate 
anions of nucleic acids. As a simplified treatment of the complicated binding event, the total cation 
and anion concentrations of the two respective species were kept at a 1:1 ratio. The titration data 
was then used to derive apparent binding constants for the ion-pair complexes of ssDNA-21SOF-
a, ssDNA-23SOF-a, dsDNA-21SOF-a and dsDNA-21SOF-a to be 1.44  105, 1.96  105, 
1.65  105 and 9.3  104 M-1, respectively. For the four ion-pair complexes of SOF-g, the values 
were determined to be 5.35 ×105, 2.66 ×105, 2.39 ×106, and 5.85 ×106 M-1, respectively. All the 
results indicated strong binding of SOFs towards the DNAs. Titration experiments were also 
conducted for longer ssDNA-58, which exhibited more complicated exo- and endothermic 
phenomena and could not be treated as for the shorter ones (Supplementary Figure 21e). The ITC 
experiments also revealed that for all the systems studied, the inclusion was driven enthalpically 
and entropically. The enthalpic contribution should come from the enhanced intermolecular ion-pair 
interaction. Whereas the entropic contribution could be rationalized by considering that the included 
DNAs might, to a great extent, cover the hydrophobic surfaces of the SOFs and consequently 
release the high energy water molecules of low freedom from the hydrophobic surfaces.45 
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Fig. 3 | ITC experiments. Isothermal titration thermograms of (a) ssDNA-21 ([anion] = 2.1 
mM), (b) ssDNA-23 ([anion] = 2.3 mM), (c) dsDNA-21 ([anion] = 0.84 mM), and (d) dsDNA-
23 ([anion] = 0.92 mM) into the solution of SOF-a ([cation] = 0.20 mM) at 25 C. The 
injection volume of the DNAs was 2 μL. [anion] represents the total phosphate 
concentration of the DNAs and [cation] represents the total pyridinium concentration of 
SOF-a. 
Intracellular delivery. Previous studies demonstrated that SOFs could quickly enter cells after 
incubation and deliver dianionic pemetrexed into tumor cells through endocytosis.33 The 
intracellular delivery of SOFs for short DNAs was then investigated using Cy5-labeled ssDNA 
(Cy5-ssDNA-21) for 293A cell line by staining the nuclei with 4’,6-diamidino-2-phenylindole 
(DAPI) and the cells with adducin -antibody (H-100, ADD), respectively. After incubation with 
Cy5-ssDNA-21SOF-a (0.25 and 14 g, respectively) for 4 h, the cells were examined by confocal 
laser scanning microscopy (CLSM). It was found that the fluorescence signal of the Cy5 dye was 
very clear and highly overlapped with that of DAPI-stained nuclei and ADD-stained cells. In 
contrast, in the absence of SOF-a, no fluorescence of the Cy5 dye was observed for free Cy5-
ssDNA-21 of the identical dosage (Supplementary Figure 22), clearly supporting that SOF-a was 
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capable of delivering Cy5-ssDNA-21 into 293A cells. We then further examined the delivery of 
more amount of Cy5-ssDNA-21 (2.5 g) into 293A cells by SOF-a and the commercial reagent 
Lipo2000 at the identical dosage (7.0 g) in the presence of fetal bovine serum (FBS, 5%). As 
expected, within the time studied (up to 2 h), no endocytosis of Cy5-ssDNA-21 (2.5 g) was 
observed in the absence of added carriers. For cells treated with Lipo2000, weak fluorescence of the 
Cy5 dye was observed in the cells within 1 h. However, no uniform transfection could be achieved 
even after 2 h (Figure 4 and Supplementary Figure 23). In contrast, with the treatment of SOF-a at 
the same dosage, the fluorescence of the Cy5 dye was considerably stronger and uniform 
transfection was observed in 2 h. 
 
Fig. 4 | Intracellular delivery of Cy5-ssDNA-21 by SOF-a. Confocal laser scanning 
microscopic images of 293A cells after incubation for 2 h with Cy5-ssDNA-21, Cy5-ssDNA-
21Lipo2000 and Cy5-ssDNA-21SOF-a. The amount of ssDNA, Lipo2000 and SOF-a 
used was 2.5, 7.0 and 7.0 g, respectively. Nuclei were stained with DAPI (blue), and cells 
were stained with ADD (green). 
 
The intracellular delivery of DNAs using SOF carriers was then further tested using flow 
cytometry. Testing was first conducted with Cy5-ssDNA-21 (2.5 g) for 293A cell line. Again, 
Lipo2000 (7.0 g) was used for comparison and the results were recorded after incubation in 10% 
FBS for 15 min, 1 h and 2 h to get insight into the delivery process (Figure 5a and supplementary 
Figure 24). In the absence of a carrier, no intracellular DNA delivery was observed. In 15 min, 
Lipo2000 and SOF-a,b,d-g (7.0 g) induced 0.1% to 8.9% transfection, suggesting their negligible 
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or low delivery efficacy, whereas SOF-c realized a remarkable 45.2% transfection. In 1 h and 2 h, 
the transfection efficiency of SOF-c reached 93% and 98.9%, which were again significantly higher 
than that of Lipo2000 (27.2% and 57.5%) and other SOFs, whereas the transfection efficacy of 
SOF-a,e-g was comparable or higher than that of Lipo2000. These tests have also shown very good 
repeatability (Supplementary Figure 25). Control experiments show that under the identical 
experimental conditions, tetrahedral monomers 1a-g exhibited limited transfection efficacy 
(Supplementary Figure 26) with 1a and 1c showing the highest efficacy of 19.1-27.7% and 13.2-
17.7%. This result strongly supports that the porous architectures of SOF-a-g remarkably enhanced 
their capacity of including and transfecting nucleic acids.  
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Fig. 5 | Transfection experiment of Cy5-labeled DNAs by SOFs: (a) Cy5-ssDNA-21 
(2.5 g) by SOF-a-g (7.0 g) for 293A cell line, (b) Cy5-dsDNA-21 (4.8 g) by SOF-a,c,e-g 
(7.0 g) for 293A cell line, (c) Cy5-dsDNA-58 (4.8 g) by SOF-a,c,e-g (7.0 g or 56 g for 
blue) for 293A cell line, (d) Cy5-ssDNA-21 (2.5 g) by SOF-a,c,e-g (7.0 g) for HPDE, 
PANC-1, Capan-1,SiHA, H1299, HeLa, and CaCo-2 cell lines, and (e) Cy5-dsDNA-21 (4.8 
g) by SOF-a,c,e-g (7.0 or 14 g) for HPDE, PANC-1, Capan-1, SiHA, H1299, HeLa, and 
CaCo-2 cell lines. Lipo2000: 7.0 g for ssDNA and 14 g for dsDNA. II: 14 g of SOFs. 
Because SOF-b and SOF-d generally exhibited the lowest transfection efficacy, we then focused 
on other SOFs SOF-a,c,e-g and extended the investigation to determine their potentials in 
  
12 
transfecting Cy5-ssDNA-21 (2.5 g) into different cell lines, including HPDE and six cancer cells 
(PANC-1, Capan-1, SiHA, H1299, Hela and CaCo-2). The detections were all performed after 
incubation in 10% PBS for 2 h (Figure 5d and Supplementary Figures 27-30). In the blank test 
without the carriers, about 5% of Hella cells were transfected by passive transportation of the 
nucleic acid, whereas all other cells underwent less than 1% of transfection. With Lipo2000 (7.0 g) 
as the carrier, the transfection efficiency of the seven cell lines was 80.0-81.9%, 20.3-33.0%, 64.5-
68.3%, 73.6-76.6%, 70.0-81.9%, 66.4-69.1%, or 13.3-16.1%, respectively. With SOFs (7.0 g) as 
the carriers, in all 35 SOF cases, 32 systems displayed transfection efficiency that was higher than 
that of Lipo2000 for the same cell line, except that of H1299 by SOF-e (61.9-68.5%) and SOF-f 
(68-76.3%) and of CaCo-2 by SOF-a (8.4-9.6%). Moreover, for all the seven cell lines, the 
transfection efficacy of SOF-c and SOF-g was always higher than Lipo2000. In addition, among 
the 35 series, 19 samples reached >90% of transfection efficiency and 10 samples reached >95% of 
transfection efficiency. 
The intracellular delivery of the above five SOF carriers for Cy5-dsDNA-21 (4.8 g), which is 
composed of Cy5-ssDNA-21 and the complementary single-stranded DNA of 21 nt, into 293A cell 
line was then investigated (Figure 5b and Supplementary Figure 31). Blank test showed that the 
transfection of the cells by passive diffusion of the nucleic acid was negligible. Preliminary test 
showed that the transfection efficacy of Lipo2000 was considerably lower and thus its amount was 
increased to14 g, whereas that of the SOF carriers was still unchanged (7.0 g). However, in all 
cases detected at different times (15 min, 1 h, and 2 h), the five SOF carriers still exhibited higher 
transfection efficiency than Lipo2000. Remarkably, SOF-c could realize 95.7% of transfection 
efficiency in 1 h, and 97.3% in 2 h. The other four SOFs could induce 59%-83% of transfection 
efficiency in 2 h, whereas in the same timeframe, Lipo2000 could only reach 46.6%.  
The transfections of the five SOFs for HPDE, PANC-1, Capan-1, SiHA, H1299, HeLa, and 
CaCo-2 cell lines were then further tested (Figure 5e and Supplementary Figures 32-35). For this 
series of experiments, the amounts of Cy5-dsDNA-21 and Lipo2000 were also maintained at 4.8 
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and 14 g, whereas the SOF carriers was tested at two doses of 7.0 and 14 g. Lipo2000 exhibited 
60.6%-90.1% of transfection efficiency. Compared with that of the corresponding cell line, 34 out 
of the total 50 SOF samples exhibited higher transfection efficacy, with 14 reaching over 90% of 
transfection efficacy. Among the 25 samples using 14 g of SOFs, 23 exhibited higher transfection 
efficiency than that of the Lipo2000 reference.  
Finally, we also tested the transfection of the longer Cy5-dsDNA-58 in the 293A cell line, which 
is composed Cy5-ssDNA-58 and the corresponding un-labeled complementary nucleic acid of 58 nt 
(Figure 5c and Supplementary Figures 36). At the dose of 4.8, 14 and 7.0 μg for DNA, Lipo2000 
and SOFs, respectively, the transfection efficiency of the five SOFs was all lower than that of 
Lipo2000 after 15 min, 1 h or 2 h of incubation. The Lipo2000-assisted transfection efficacy was. 
However, when the dose of SOFs was increased to 56 μg, their transfection efficiency in 2 h all 
surpassed Lipo2000 (82.6%), with SOF-c realizing a highest efficiency of 96.8%. 
Discussion 
The driving forces for the inclusion of DNAs by SOFs were mainly electrostatic attraction and 
hydrophobicity. Because the inclusion occurred homogeneously, the release of the included DNAs 
should highly depend on the above two interactions. The dynamic feature of this inclusion process 
suggests that the included DNA could be released through simple diffusion. Previous in vivo 
fluorescence imaging of SOF-a showed that the framework accumulated in tumor cells and then 
was metabolized or degraded in cells.33 Thus, another important route for the release of the included 
DNA was through the decomposition of the framework. The above CLSM experiments also 
indicated that the labeled DNAs diffused into all the area of the nuclei, as observed for the delivery 
of molecular drugs. 
   In summary, we demonstrate that water-soluble supramolecular organic frameworks can 
efficiently include short DNAs in a homogeneous manner and realize intracellular delivery into 
both normal and cancer cells. With the identical carrier loading, in most cases, supramolecular 
organic frameworks exhibit higher transfection efficacy than the commercial reagent Lipo2000, 
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with SOF-c exhibiting the most promising transfection efficacy. These water-soluble self-assembled 
entities represent a novel class of off-the-shelf gene-delivery carriers that feature easy formulation, 
high stability and in situ DNA inclusion. In the future, this promising strategy will be explored for 
the transfection of siRNA. 
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